Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Deloitte
Cipla
McKinsey
UBS
Cerilliant
Medtronic
AstraZeneca

Generated: December 18, 2018

DrugPatentWatch Database Preview

Bupivacaine - Generic Drug Details

« Back to Dashboard

What are the generic sources for bupivacaine and what is the scope of bupivacaine patent protection?

Bupivacaine is the generic ingredient in thirteen branded drugs marketed by Pacira Pharms Inc, Aurobindo Pharma Ltd, Hospira, Mylan Asi, Intl Medicated, Fresenius Kabi Usa, Baxter Hlthcare Corp, Septodont, and Amphastar Pharms Inc, and is included in thirty-eight NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Bupivacaine has forty-one patent family members in fifteen countries.

There are eleven drug master file entries for bupivacaine. One supplier is listed for this compound.

Pharmacology for bupivacaine
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Medical Subject Heading (MeSH) Categories for bupivacaine
Synonyms for bupivacaine
( inverted exclamation markA)-bupivacaine
(.+/-.)-1-Butyl-2',6'-pipecoloxylidide
(.+/-.)-Bupivacaine
(+-)-Bupivacaine
(+/-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(inverted exclamation markA)-bupivacaine
(RS)-bupivacaine
1-butyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylidide
1-butyl-2-(2,6-xylycarbamoyl)piperidine
1-Butyl-2',6'-pipecoloxylidide
1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecarboxamid
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
14252-80-3 (HCl)
18010-40-7 (HCl)
180B929
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (.+/-.)-
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-
2',6'-Pipecoloxylidide, 1-butyl-
2180-92-9
38396-39-3
4CH-013994
73360-54-0 (HCl.H2O)
AB00053674
AB00053674_10
AB00053674_11
AB00053674-08
AB00053674-09
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AK-90074
AKOS001637202
AKOS016842516
AN-14284
Anekain
ANW-45984
API0007792
AX8041457
BDBM50350790
Bio-0886
Bloqueina
BPBio1_000298
BRD-A01636364-003-05-2
BRD-A01636364-003-08-6
BS-5224
BSPBio_000270
BSPBio_002607
bucain
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (INN)
Bupivacaine (USAN/INN)
Bupivacaine [INN:BAN]
Bupivacaine [USAN:INN:BAN]
bupivacaine base
Bupivacaine Carbonate
Bupivacaine HCL KIT
Bupivacaine hydrochloride anhydrous
Bupivacaine liposome injectable suspension
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine,hydrochloride
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
Carbostesin
cBupivacaine
CHEBI:3215
CHEBI:77431
CHEMBL1098
CS-W023182
CTK8B4736
D07552
D0A0FL
DB00297
DepoBupivacaine
DivK1c_000758
dl-1-Butyl-2,6-pipecoloxylidide
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DTXSID2022703
DUR-843
EINECS 218-553-3
EINECS 253-911-2
Epitope ID:122662
Exparel
Exparel (TN)
FT-0623286
FT-0699781
GTPL2397
HE058460
HE301859
HMS2090F12
HMS3428P06
HSDB 7790
IDI1_000758
J10217
KB-218680
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KS-00000ZRC
L000695
LAC-43
LAC-43 (Salt/Mix)
LEBVLXFERQHONN-UHFFFAOYSA-N
LP075507
LS-109841
LS-2222
M-9606
Marcain (TN)
Marcaina
Marcaine
Marcaine (TN)
Marcaine HCL
Marcaine hydrochloride (Salt/Mix)
Marcaine Spinal
Marcaine spinal (Salt/Mix)
MCULE-2286784276
MFCD00243007
MFCD00941462
MolPort-004-955-820
N-(2,6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide
NCGC00178579-01
NCGC00178579-02
NINDS_000758
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Q-100271
R962
racemic bupivacaine
SBI-0051846.P002
SC-26838
SCHEMBL25438
Sensorcaine
Sensorcaine (TN)
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Sensorcaine-MPFSpinal
SKY 0402
SKY-0402
SKY0402
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
ST065773
ST2415271
STL484283
TC-134729
Transdur-Bupivacaine
Vivacaine (TN)
Win 11318
Win 11318 HCl

US Patents and Regulatory Information for bupivacaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira MARCAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 016964-009 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Asi BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 091487-003 Oct 18, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 070609-001 Mar 3, 1987 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 070585-001 Mar 3, 1987 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 022046-001 Jul 13, 1983 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amphastar Pharms Inc DUOCAINE bupivacaine hydrochloride; lidocaine hydrochloride INJECTABLE;INJECTION 021496-001 May 23, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride INJECTABLE;INJECTION 070554-001 May 21, 1986 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for bupivacaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-002 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc EXPAREL bupivacaine INJECTABLE, LIPOSOMAL;INJECTION 022496-001 Oct 28, 2011 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Deloitte
Cipla
McKinsey
UBS
Cerilliant
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.